Carregant...
Fitxers
Tipus de document
Part del llibreVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/175395
Don’t Take Away My P: Phosphatases as Therapeutic Targets in Huntington’s Disease
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
The molecular bases that account for the preferential neurodegeneration of striatal mediumsized
spiny neurons (MSNs) in Huntington’s Disease (HD) are still unknown, and different
mechanisms have been proposed to contribute to the neurodegenerative process.
These include mitochondrial dysfunction and metabolic impairment, transcriptional
dysregulation, altered expression of trophic factors, dopamine toxicity, oxidative stress, and
changes in autophagy, and huntingtin (htt) phosphorylation. In addition, excitotoxicity
through the overactivation of N-methyl-D-aspartate (NMDA) receptors (NMDARs) has also
been proposed to contribute to the preferential loss of these neurons (for review see
Ehrnhoefer et al., 2011; Jin & Johnson, 2010; Perez-Navarro et al., 2006; Renna et al., 2010;
Rosenstock et al., 2010; Weir et al., 2011).
Some of these mechanisms are controlled by the attachment/removal of phosphate groups
through the action of protein kinases and protein phosphatases, respectively. Therefore,
alterations in their levels/activity in the presence of mutant htt (mhtt) can impact on cell
survival...
Matèries
Matèries (anglès)
Citació
Col·leccions
Citació
SAAVEDRA, Ana, ALBERCH I VIÉ, Jordi, PÉREZ NAVARRO, Esther. Don’t Take Away My P: Phosphatases as Therapeutic Targets in Huntington’s Disease. _Chapter 20 in: Ersoy Tunali_. Nagehan. 2012. Huntington's Disease: Core Concepts and Current Advances. IntechOpen. ISBN: 978-953-51-4359-8. DOI: 10.5772/1470. pp: 465-494.. [consulta: 24 de gener de 2026]. [Disponible a: https://hdl.handle.net/2445/175395]